Welcome to DukeHealth.org.
Skip over navigation
Skip over navigation
- Home
- Patient and Visitor Info
- Physicians
- Services
- Clinical Trials
- Event Calendar
- Locations
- Health Library
- About Duke Medicine
Quick Links
Home
>
Clinical Trials
>
Trial of a Monoclonal Antibody to CD20 (rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Trial of a Monoclonal Antibody to CD20 (rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Share
The primary objective of this study is to compare patients with scleroderma-related pulmonary arterial hypertension (PAH) treated with rituximab to those on placebo.
For more information, contact Melissa Willis, RN at 919-684-6237.
(REF# 26635)
